Overview

Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease

Status:
Completed
Trial end date:
2022-07-22
Target enrollment:
Participant gender:
Summary
The study is being conducted to assess the efficacy, safety and tolerability of SHR8028 eye drops in comparison to the vehicle for the treatment of dry eye disease.
Phase:
Phase 3
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Ophthalmic Solutions